Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

Saved in:
Bibliographic Details
Title: Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Authors: Jehanno N; Department of Nuclear Medicine, Curie Institute, Paris, France. nina.jehanno@curie.fr., Corradini N; Department of Pediatric Oncology, Institute for Paediatric Haematology and Oncology, Léon Bérard Center, Lyon, France., Gaspar N; Department of Oncology for Child and Adolescent, Gustave Roussy Cancer Campus, Villejuif, France., Brahmi M; Department of Medical Oncology, Léon Bérard Center, Lyon, France., Valentin T; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Revon Rivière G; Department of Pediatric Hematology, Immunology and Oncology, APHM - La Timone Children's Hospital, Marseille, France., Lervat C; Department of Pediatric and AYA Oncology, Centre Oscar Lambret, Lille, France., Probert J; Department of Pediatric Onco-hematology, University Hospital of Rennes, Rennes, France., Entz-Werle N; Department of Pediatric Oncology, CHU, Strasbourg, France., Mansuy L; Children's University Hospital, Department of Pediatric Hematology and Oncology, Nancy, France., Plantaz D; Department of Pediatric Hematology and Oncology, University Hospital of Grenoble, Grenoble, France., Rios M; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France., Saumet L; Department of Pediatric Onco-Hematology, University Hospital of Montpellier, Montpellier, France., Verité C; Department of Pediatric and Adolescent Hematology and Oncology, Pellegrin Hospital, Bordeaux, France., Castex MP; Pediatric Oncology Immunology Hematology Unit, Children's University Hospital - Toulouse University Hospital, Toulouse, France., Thebaud E; Department of Pediatric Oncology, Hôpital Mère-Enfant, Nantes, France., Cassou-Mounat T; Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Plissonnier AS; DREH Pôle Promotion, Institut Curie, Saint-Cloud, France., Mosseri V; Department of Biostatistics, Curie Institut, Saint-Cloud, France., Cordero C; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France., Laurence V; Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.
Source: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1605-1612. Date of Electronic Publication: 2024 Oct 08.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-024-02864-8